The expression of the VEGF-D gene close to the limit of detection (10−7-fold change to CD31) observed in tumor-adjacent normal tissues from LVI-/Ln- NMIBC patients could have led to overestimation of the VEGF-D expression level in this group of patients. This evidence concerns the gene VEGFD and neoplasm.